These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2409670)

  • 1. Human cytomegalovirus polypeptides stimulate neutralizing antibody in vivo.
    Rasmussen L; Mullenax J; Nelson M; Merigan TC
    Virology; 1985 Aug; 145(1):186-90. PubMed ID: 2409670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of two different human cytomegalovirus glycoproteins which are targets for virus neutralizing antibody.
    Rasmussen L; Nelson M; Neff M; Merigan TC
    Virology; 1988 Apr; 163(2):308-18. PubMed ID: 2833009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral polypeptides detected by a complement-dependent neutralizing murine monoclonal antibody to human cytomegalovirus.
    Rasmussen L; Mullenax J; Nelson R; Merigan TC
    J Virol; 1985 Aug; 55(2):274-80. PubMed ID: 2410626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune response to guinea pig cytomegalovirus polypeptides and cross reactivity with human cytomegalovirus.
    Kacica MA; Harrison CJ; Myers MG; Bernstein DI
    J Med Virol; 1990 Nov; 32(3):155-9. PubMed ID: 2177780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune responses to isolated human cytomegalovirus envelope proteins.
    Gönczöl E; Hudecz F; Ianacone J; Dietzschold B; Starr S; Plotkin SA
    J Virol; 1986 May; 58(2):661-4. PubMed ID: 3009877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the presence of cytomegalovirus-neutralizing antibody by a plaque-reduction assay.
    Lewis RB; Matzke DS; Albrecht TB; Pollard RB
    Rev Infect Dis; 1986; 8 Suppl 4():S434-8. PubMed ID: 3018894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human immune response to cytomegalovirus structural polypeptides studied by immunoblotting.
    Landini MP; Re MC; Mirolo G; Baldassarri B; La Placa M
    J Med Virol; 1985 Dec; 17(4):303-11. PubMed ID: 3001220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the antibodies elicited by the individual structural polypeptides of foot-and mouth disease and polio viruses.
    Meloen RH; Rowlands DJ; Brown F
    J Gen Virol; 1979 Dec; 45(3):761-3. PubMed ID: 94352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plaque reduction neutralization test for human cytomegalovirus based upon enhanced uptake of neutral red by virus-infected cells.
    Schmidt NJ; Dennis J; Lennette EH
    J Clin Microbiol; 1976 Jul; 4(1):61-6. PubMed ID: 182716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation of highly purified human cytomegalovirus envelope antigen.
    Hudecz F; Gonczol E; Plotkin SA
    Vaccine; 1985 Sep; 3(3):300-4. PubMed ID: 2998113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human monoclonal antibodies neutralizing human cytomegalovirus.
    Masuho Y; Matsumoto Y; Sugano T; Fujinaga S; Minamishima Y
    J Gen Virol; 1987 May; 68 ( Pt 5)():1457-61. PubMed ID: 2437245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of cytomegalovirus antibodies by means of CF, ELISA and immunoblotting techniques.
    Jankowski M; Styczyński P
    Arch Immunol Ther Exp (Warsz); 1987; 35(3):313-9. PubMed ID: 2833198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody responses to murine cytomegalovirus in genetically resistant and susceptible strains of mice.
    Lawson CM; Grundy JE; Shellam GR
    J Gen Virol; 1988 Aug; 69 ( Pt 8)():1987-98. PubMed ID: 2841411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microneutalization of cytomegalovirus.
    Stalder H; Ehrensberger A
    J Infect Dis; 1980 Jul; 142(1):102-5. PubMed ID: 6249870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nature of the antibody response to the foot-and-mouth disease virus particle, its 12S protein subunit and the isolated immunizing polypeptide VP1.
    Cartwright B; Morrell DJ; Brown F
    J Gen Virol; 1982 Dec; 63(2):375-81. PubMed ID: 6296284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of neutralizing antibodies and immunity in vaccinated guinea pigs by cyanogen bromide-peptides of VP3 of foot-and-mouth disease virus.
    Kaaden OR; Adam KH; Strohmeier K
    J Gen Virol; 1977 Feb; 34(2):397-400. PubMed ID: 65445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of complement on the neutralization of murine cytomegalovirus by rabbit antibody.
    Kim KS; Carp RI
    J Virol; 1973 Dec; 12(6):1620-1. PubMed ID: 4357520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutralizing antibody to Mengo virus, induced by synthetic peptides.
    Muir S; Weintraub JP; Hogle J; Bittle JL
    J Gen Virol; 1991 May; 72 ( Pt 5)():1087-92. PubMed ID: 1709682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological priming with synthetic peptides of foot-and-mouth disease virus.
    Francis MJ; Fry CM; Rowlands DJ; Brown F; Bittle JL; Houghten RA; Lerner RA
    J Gen Virol; 1985 Nov; 66 ( Pt 11)():2347-54. PubMed ID: 2997370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between antibody titres against human cytomegalovirus detected by enzyme immunoassay and titres to individual viral polypeptides studied by immunoblotting.
    Mirolo G; Landini MP; Baldassarri B; Re MC; Lazzarotto T; La Placa M
    Microbiologica; 1986 Jul; 9(3):373-9. PubMed ID: 3018455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.